XPhyto Therapeutics Debuts on CSE Under Ticker XPHY
August 6, 2019
Ryan Allway August 6th, 2019 App, Exclusive, News, Top News After about two years of building relationships with exceptional partners and positioning itself in Canada and Europe, XPhyto Therapeutics (CSE: XPHY) was ready to become a public company. That happened Tuesday morning, with trading beginning on the Canadian Securities... Read more
Ash Stringer August 5th, 2019 App, Exclusive, News, Top Story As the cannabis market moves from the back alley to the boardroom, we are gaining an increasing appreciation for the role genetics play in developing distinct varieties with unique medical and commercial application. As the cannabis market matures, the... Read more
Ryan Allway August 2nd, 2019 Exclusive, News, Top Story, Uncategorized Only days after announcing that its wholly owned subsidiary was awarded a German cannabis and cultivation and extraction licence, XPhyto Therapeutics is ready to enter the public domain. With a final prospectus filed with the British Columbia Securities Commission,... Read more
Ryan Allway August 1st, 2019 App, Exclusive, News, Top Story The cannabis industry is quickly moving through a well-known cycle for emerging markets. Like Google in the tech industry, early market entrants that have become successful in a given subset of the fragmented market are starting to look to... Read more
Ryan Allway July 15th, 2019 NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) — RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that its dose-measuring smart vaporizer and proprietary cartridges have hit medical dispensary shelves in the United States. RYAH selected Sweetspot, a high-end medical dispensary located in Maryland... Read more
Ryan Allway July 10th, 2019 App, Exclusive, News, Top Story As we know, a growing number of states have legalized medical and adult-use cannabis, creating a robust industry worth billions of dollars per year. The problem is that cannabis remains illegal on a federal level, which has left states... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Ash Stringer June 28th, 2019 Uncategorized The output of analyzing large blocks of information, or “big data” as it is generally known, to identify trends is one of the most valuable commodities today. One of the beauties of big data is that it can pinpoint trends at all scales,... Read more
Ryan Allway June 26th, 2019 App, Exclusive, News, Top Story Many people hear the phrase ‘synthetic’ cannabinoids and immediately think of deadly designer drugs that have swept the recreational market. But synthetic cannabinoids refer to any cannabinoids that are created through chemical or biological processes other than the cultivation... Read more
Ryan Allway June 22nd, 2019 Uncategorized Cannabis edibles and beverages have more than doubled their share of the overall cannabis market since 2011, according to data from ArcView Market Research and BDS Analytics, with revenue projected to grow from $1 billion in 2017 to $4.1 billion by 2022. Consumer... Read more
